Regnase-1 is essential for B cell homeostasis to prevent immunopathology

J Exp Med. 2021 May 3;218(5):e20200971. doi: 10.1084/jem.20200971.

Abstract

Regnase-1 is an emerging regulator of immune responses with essential roles in the posttranscriptional control of immune cell activation. Regnase-1 is expressed in B cells; however, its B cell-specific functions remain unknown. Here, we demonstrate that Regnase-1 prevents severe autoimmune pathology and show its essential role in maintaining B cell homeostasis. Using Cre driver mice for ablation of Regnase-1 at various stages of B cell development, we demonstrate that loss of Regnase-1 leads to aberrant B cell activation and differentiation, resulting in systemic autoimmunity and early morbidity. The basis of these findings was informed by gene expression data revealing a regulatory role for Regnase-1 in the suppression of a transcriptional program that promotes B cell activation, survival, and differentiation. Overall, our study shows that Regnase-1 exerts critical control of B cell activation, which is required for prevention of immunopathology.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autoimmunity / genetics*
  • B-Lymphocytes / metabolism*
  • Cell Differentiation / genetics
  • Gene Expression Profiling / methods
  • Homeostasis / genetics*
  • Lymphocyte Activation / genetics*
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • RNA-Seq / methods
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Ribonucleases / genetics*
  • Ribonucleases / metabolism

Substances

  • Ribonucleases
  • Zc3h12a protein, mouse